Lake Shore Gazette

Leading News Website

The Next Decade To Witness A Shift To Digitization In Dural Graft Market At US$ 1.1 Billion Between 2019 to 2029

The Global Dural Graft Market Share is slated to reach US$ 1.1 Billion at the rate of 6% from 2019 to 2029. With the world getting digitally transformed, the healthcare vertical is no exception. The frequency of testing platforms using AI for rendering usefulness, precision, and simplicity on the part of diagnosis is increasing at an alarming rate. This trend is expected to keep the healthcare vertical on the toes even going forward.

Global demand for dural graft is expected to grow significantly, owing to rising burden of neurosurgical diseases leading to increasing cranial and spinal duraplasty, and rapid technological advancements in dural graft products.

Moreover, increasing global neurosurgical workforce, extensive clinical research, and increasing demand for CNS dural repair are responsible for increasing the adoption of dural graft products.

Planning Forward? Access Sample Of Dural Graft Market Report! https://www.persistencemarketresearch.co/samples/25285

Company Profiles

  • Cook Medical.
  • Integra Lifesciences Corporation
  • B Braun
  • Cousin Biotech,
  • Natus Medical Incorporated
  • Tissuemed Ltd,
  • Vostra GmbH
  • Stryker Corporation
  • Medtronic Plc.
  • Johnson & Johnson,
  • Aesculap, Inc.
  • Baxter International Inc

Persistence Market Research predicts that, the global dural graft market will exhibit a 6% CAGR during the forecast period (2019-2029).

Key Takeaways of Dural Graft Market Study

  • By product type, synthetic dural graft along with xenogeneic dural graft are expected to gain traction during the forecast period.
  • Technological advancements in material science of dural graft products in North America and Europe are expected to contribute to the significant dominance of these regions during the forecast period.
  • Brain and spine tumor applications are expected to hold more than 50% share in the global dural graft market.
  • Synthetic polymer material is expected to gain significant traction and experience 2X demand by 2029.
  • Leading dural graft manufacturing companies are partnering with innovative product developers and specialized distributors to strengthen their market position.
  • Rising healthcare expenditure and increasing neurosurgeon workforce density in East Asia are expected to offer significant opportunities for market growth.

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Dural Graft Market? https://www.persistencemarketresearch.co/methodology/25285

“Increasing scientific evidence from industry-led clinical trials and technological advancements in dural graft products are expected to support the significant adoption of synthetic nanofibrous dural grafts.” says a PMR analyst.

Brain and Spinal Tumor Application Dominating Dural Graft Market

Prevalence of CNS tumors due to neurological conditions is growing rapidly. Chiari malformation and spinal cord tumor-related neurosurgical procedures requiring dural grafts for surgeries are becoming more frequent. Growing risk of such neurological conditions demands neurosurgical procedures along with duraplasty for effective and safe treatment outcomes.

For instance, in 2018, more than 50% of dural grafts were used in cranial and spine tumor operations. This high proportion is estimated to continue in the future.

Planning To Introduce An Offbeat Product/Technology In The Dural Graft Market? Go To “Purchase Now” To Have Our Dural Graft Market Report! https://www.persistencemarketresearch.com/checkout/25285

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the dural graft market in its latest study, presenting historical demand assessment from 2014-2018 and projections for 2019-2029, on the basis of product type (xenogeneic dural graft, synthetic dural graft, autologous dural graft, and allogeneic dural graft), application (brain and spine tumor, traumatic brain and spine injury, cerebrospinal fluid (CSF) accumulation, cerebrovascular accident, epilepsy, and others), material (bovine pericardium, autologous pericardium, synthetic polymers, ligamentum nuchae, and others), and end user (hospitals, ambulatory surgical centers, trauma centers, and clinics), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *